STING1 and acute respiratory distress syndrome: First, in the field of therapeutic target identification, studies have confirmed that inhibiting the cGAS‐STING pathway or platelet glycoprotein VI (GPVI) can significantly alleviate NETs–mediated ALI, suggesting that these may serve as novel therapeutic targets for ALI/ARDS [5, 6].